Cxcr4 agonist treatment of hematopoietic cells

Details Cxcr4 agonist treatment of hematopoietic cells Cxcr4 agonist treatment of hematopoietic cells

A - Human Necessities

61

K

A61K 38/19 (2006.01) A61K 35/12 (2006.01) A61K 35/28 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2335109

In accordance with various aspects of the invention, CXCR4 agonists may be used to treat bone marrow progenitor or stem cells to reduce the susceptibility of the cells to cytotoxic agents. CXCR4 agonists may be used to treat bone marrow progenitor cells or stem cells to reduce the rate of cellular multiplication. CXCR4 agonists may be used to treat cancer in a mammal in conjunction with one or more cytotoxic agents. Cytotoxic agents may for example include chemotherapeutic agents or radiation. CXCR4 agonists may be used therapeutically to regulate bone marrow progenitor or stem cell growth in human diseases, such as cancer.

Affiliated with

Also associated with

Rating

Cxcr4 agonist treatment of hematopoietic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cxcr4 agonist treatment of hematopoietic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cxcr4 agonist treatment of hematopoietic cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1971264